In a recent episode of the Longevity Optimization Podcast, health optimization expert Kayla Barnes sits down with Kevin Ferber, American Cell Technologies COO, to explore how banking your own stem cells could be the future of health and longevity. Based in South Florida, American Cell Technology is the largest personal (autologous) stem cell bank in the U.S., specializing in isolating and expanding an individual’s own mesenchymal stem cells (MSCs) from a small fat or bone marrow sample. These cells are processed under FDA-registered and inspected conditions, ensuring the highest safety and quality standards.
Unlike donor-based products or mass-produced cell lines, ACT focuses exclusively on autologous stem cells—meaning your own DNA. This eliminates the risk of rejection, reduces exposure to unknown infections, and ensures that your cells remain viable and effective for decades. Using a simple, minimally invasive procedure, a small amount of fat is harvested, the stem cells are isolated and expanded naturally, and then cryopreserved for lifelong access.
Throughout the conversation, Kevin Ferber highlights the potential risks of allogeneic (donor) cells, often sourced abroad with fewer regulations. Donor cells carry a greater risk of infection, immune rejection, and are often expelled from the body quickly. In contrast, banking your own stem cells ensures a safer, and potentially longer-lasting regenerative effect, ideal for longevity therapies, injury recovery, and even aesthetic treatments like hair restoration and skin rejuvenation.
Kayla Barnes shares her own recent experience banking her adipose-derived stem cells with ACT. Her goal: to use these cells for quarterly longevity IV infusions and potential aesthetic procedures. Kevin explains that mesenchymal stem cells can potentially reduce inflammation, release growth factors, and help the body heal naturally—making them a powerful tool not just for treating diseases but also for optimizing healthspan.
The podcast also touches on ACT’s newborn division, VitalCells, which offers expanded newborn stem cell banking. Unlike traditional cord blood banks that store samples with limited value offering, VitalCells isolates and grows the actual stem cells, providing a much larger, usable reserve for future therapies. You can visit VitalCells at www.vitalcells.com.
With more than 9,000 clinical trials globally investigating the uses of mesenchymal stem cells, the possibilities are expanding rapidly. As Kevin Ferber explains, having access to your own stem cells may soon become a core pillar of personalized healthcare and longevity planning.
To learn more about personal stem cell banking, contact us today.
